Francis Santens, PhDPrincipal Scientist Molecular Engineering at Confo TherapeuticsSpeaker
Profile
Francis Santens, PhD, is Principal Scientist Molecular Engineering at Confo Therapeutics, where he leads efforts in antibody engineering, formatting, humanization and analysis. Prior to joining Confo Therapeutics, he was Senior Scientist in Protein Engineering at Precirix, a biotech company developing targeted radiopharmaceuticals based on antibody-drug conjugates (ADCs). He obtained his PhD in protein engineering from Ghent University (VIB).
Agenda Sessions
Agonistic Antibodies for GPCR Modulation: Unlocking New Therapeutic Avenues in Obesity
, 11:00amView Session